top of page
Researcher

VACCELERATE

Start Date:

February 2021

End Date:

ongoing

Duration:

36 Months

ID-CARE Role:
Website:

Partner

Description

GA Number: 101037867


Title: VACCELERATE - The  New European Vaccine Research Network


Design: Phase  2 & 3 COVID-19 vaccine clinical trials


Volunteer Registry: VACCELERATE has a created the Volunteer Registry (www.vaccelerate.eu/volunteer-registry), a tool through which it aims to involve the general population by providing direct access to trials on new vaccines for infectious diseases. The Volunteer Registry is available in 22 countries and in several local languages. More countries are joining. More than 100,000 volunteers already registered.


Background: VACCELERATE is a network for pandemic preparedness in Europe, planning and coordinating phase 2 & 3 vaccine trials in all EU-member states and EU-associated countries under one  strategic-scientific umbrella. It serves as a single-entry point for all stakeholders involved in COVID-19 vaccine development (pharma, academia, European Commission, EMA, ECDC, national health authorities and others).


Objective(s):

  • To address any research question outside the big registration trials, such as vaccine efficacy in case of virus variants, trials in children, pregnant women and immuno- compromised patients, trials on combination of different vaccines etc.

  • Creation of a Stakeholder Working Group (SWG) to facilitate strategic discussions and to identify unanswered public health needs.

  • Promotion  of a harmonised  acquisition, open exchange and consolidation of data for enhanced data analysis across trial through  the setting up of volunteer registries.

Additionally, VACCELERATE addresses vaccine hesitancy through systematic reviews of available  information and through specific information material to dispel myths about vaccines and clinical trials.

Partners

Klinikum Der Universitaet Zu Koeln (UHC) - GERMANY

Biomedicinske Centrum Slovenskej Akademie Vied - SLOVAKIA

Centro Hospitalar Universitario Do Porto Epe - PORTUGAL

Kentro Klinikis Epidimiologias Kai Ekvasis Nosimaton - GREECE

Ecrin European Clinical Research Infrastructure Network - FRANCE

European University Cyprus - CYPRUS

European Vaccine Initiative Ewiv - GERMANY

Hacettepe Universitesi - TURKEY

Institut National De La Sante Et De La Recherche Medicale (INSERM) - FRANCE

Instituto De Salud Carlos III - SPAIN

Karolinska Institutet - SWEDEN

Region Stockholm - SWEDEN

University of Belgrade - SERBIA

Ministry of Health Israel - ISREAL

Uniwersytet Medyczny W Bialymstoku - POLAND

Medizinische Universitaet Wien - AUSTRIA

University College Dublin - IRELAND

Region Hovedstaden (Regionh) - DENMARK

University of Antwerp - BELGIUM

University of Bern - SWITZERLAND

University of Bergen - NORWAY

University of Utrecht - NETHERLANDS

University of Paris - FRANCE

Viesoji Istaiga Vilniaus Universiteto Ligonine Santaros Klinikos - LITHUANIA

Sponsor
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Publications

Vaccines

29/11/23

The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium

Clinical Microbiology and Infection

1/12/22

Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases

Vaccine

18/5/23

VACCELERATE site network: real-time definition of clinical study capacity in Europe

Vaccine

28/7/22

VACCELERATE volunteer registry: a European study participant database to facilitate clinical trial enrolment

JMIR Public Health and Surveillance

3/4/23

Enhancing public health communication regarding vaccine trials: design and development of the pan-European VACCELERATE toolkit

ID-CARE Participants

Evelina Tacconelli

Director

Ruth Joanna Davis

Project Officer

Anna Maria Azzini

Lecturer and Consultant Physician

Angela Musmeci

Project Assistant

Benedetta Barana

Clinical Research Assistant

bottom of page